Chanprapaph, K., Pratumchart, N., Limtong, P., Rutnin, S., Sukasem, C., Kungvalpivat, P., . . . Hospital, R. (2022). Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus.
استشهاد بنمط شيكاغوChanprapaph, Kumutnart, Nathathai Pratumchart, Preeyachat Limtong, Suthinee Rutnin, Chonlaphat Sukasem, Pintusorn Kungvalpivat, Siripich Triamchaisri, Poonkiat Suchonwanit, و Ramathibodi Hospital. Dipeptidyl Peptidase-4 Inhibitor-related Bullous Pemphigoid: A Comparative Study of 100 Patients With Bullous Pemphigoid and Diabetes Mellitus. 2022.
MLA استشهادChanprapaph, Kumutnart, et al. Dipeptidyl Peptidase-4 Inhibitor-related Bullous Pemphigoid: A Comparative Study of 100 Patients With Bullous Pemphigoid and Diabetes Mellitus. 2022.